Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-12-13 5:02 pm Purchase | 2024-12-06 | 13G | Nkarta, Inc. NKTX | CITADEL ADVISORS LLC | 3,819,867 5.400% | 3,819,867 (New Position) | Filing History |
| 2024-11-14 4:24 pm Sale | 2024-09-30 | 13G | Enliven Therapeutics, Inc. ELVN | CITADEL ADVISORS LLC | 1,734,094 3.700% | -660,354 (-27.58%) | Filing History |
| 2024-11-14 4:23 pm Sale | 2024-09-30 | 13G | Dyne Therapeutics, Inc. DYN | CITADEL ADVISORS LLC | 2,960,081 3.000% | -112,506 (-3.66%) | Filing History |
| 2024-11-14 4:21 pm Sale | 2024-09-30 | 13G | Dutch Bros Inc. BROS | CITADEL ADVISORS LLC | 2,974,719 2.600% | -1,099,167 (-26.98%) | Filing History |
| 2024-11-14 4:20 pm Purchase | 2024-09-30 | 13G | COMPASS Pathways plc CMPS | CITADEL ADVISORS LLC | 5,434,676 8.000% | 2,239,159 (+70.07%) | Filing History |
| 2024-11-14 4:20 pm Sale | 2024-09-30 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL | CITADEL ADVISORS LLC | 2,737,221 3.900% | -1,001,261 (-26.78%) | Filing History |
| 2024-11-14 4:19 pm Sale | 2024-09-30 | 13G | VistaGen Therapeutics, Inc. VTGN | CITADEL ADVISORS LLC | 1,158,219 4.200% | -442,549 (-27.65%) | Filing History |
| 2024-11-14 4:19 pm Sale | 2024-09-30 | 13G | Vigil Neuroscience, Inc. VIGL | CITADEL ADVISORS LLC | 1,442,489 3.600% | -719,413 (-33.28%) | Filing History |
| 2024-11-14 4:19 pm Sale | 2024-09-30 | 13G | Bolt Biotherapeutics, Inc. BOLT | CITADEL ADVISORS LLC | 0 0.000% | -2,458,958 (Position Closed) | Filing History |
| 2024-11-14 4:18 pm Sale | 2024-09-30 | 13G | UWM Holdings Corporation UWMC | CITADEL ADVISORS LLC | 8,995,096 7.900% | -17,254 (-0.19%) | Filing History |
| 2024-11-14 4:18 pm Sale | 2024-09-30 | 13G | Aura Biosciences, Inc. AURA | CITADEL ADVISORS LLC | 32,626 0.100% | -3,598,868 (-99.10%) | Filing History |
| 2024-11-14 4:18 pm Sale | 2024-09-30 | 13G | REV Group, Inc. REVG | CITADEL ADVISORS LLC | 1,336,604 2.600% | -1,360,669 (-50.45%) | Filing History |
| 2024-11-14 4:17 pm Sale | 2024-09-30 | 13G | NETSTREIT Corp. NTST | CITADEL ADVISORS LLC | 611,297 0.800% | -3,496,902 (-85.12%) | Filing History |
| 2024-11-14 4:17 pm Purchase | 2024-09-30 | 13G | Atara Biotherapeutics, Inc. ATRA | CITADEL ADVISORS LLC | 260,480 4.600% | 260,480 (New Position) | Filing History |
| 2024-11-14 4:17 pm Sale | 2024-09-30 | 13G | Janux Therapeutics, Inc. JANX | CITADEL ADVISORS LLC | 1,021,403 2.000% | -2,104,494 (-67.32%) | Filing History |
| 2024-11-14 4:16 pm Sale | 2024-09-30 | 13G | AN2 Therapeutics, Inc. ANTX | CITADEL ADVISORS LLC | 22 0.000% | -1,556,820 (-100.00%) | Filing History |
| 2024-11-14 4:15 pm Sale | 2024-09-30 | 13G | Allurion Technologies Inc. ALUR | CITADEL ADVISORS LLC | 4,004 0.200% | -98,545 (-96.10%) | Filing History |
| 2024-11-14 4:15 pm Sale | 2024-09-30 | 13G | Immuneering Corporation IMRX | CITADEL ADVISORS LLC | 2,672 0.000% | -2,075,420 (-99.87%) | Filing History |
| 2024-11-14 4:14 pm Sale | 2024-09-30 | 13G | Aclaris Therapeutics, Inc. ACRS | CITADEL ADVISORS LLC | 368,067 0.500% | -5,038,022 (-93.19%) | Filing History |
| 2024-11-05 4:27 pm Purchase | 2024-10-29 | 13G | Chain Bridge Bancorp, Inc. CBNA | CITADEL ADVISORS LLC | 94,882 5.100% | 94,882 (New Position) | Filing History |